![Near-infrared fluorescence and H&E counterstaining images used in bio-panning process to identify antibodies for an aggressive brain cancer called glioblastoma](https://www.med.wisc.edu/wp-content/uploads/fly-images/656/img_biopanning-344x201-c.png)
UW study uses ‘bio-panning’ to find human antibodies for brain cancer stem cells
Using a method described as similar to panning for gold, Carbone Cancer Center scientists discovered human antibodies for the cancer stem cells of glioblastoma, one of the most difficult brain cancers to treat.
![](https://www.med.wisc.edu/wp-content/themes/smph/images/card-fallback.png.webp)
New clinical tool identifies patients likely to have seizures
A new scoring system developed by a UW School of Medicine and Public Health neurologist may help physicians identify which critically ill patients are likely to have seizures.
![](https://www.med.wisc.edu/wp-content/themes/smph/images/card-fallback.png.webp)
Social-class discrimination contributes to poorer health
Discrimination felt by teenagers based on their social class background can contribute to physiologic changes associated with poorer health, according to a new study led by a University of Wisconsin–Madison researcher.
![](https://www.med.wisc.edu/wp-content/themes/smph/images/card-fallback.png.webp)
Psychopaths’ Brains Show Differences in Structure and Function
Images of prisoners’ brains show important differences between those who are diagnosed as psychopaths and those who aren’t, according to a study led by University of Wisconsin–Madison researchers.
![](https://www.med.wisc.edu/wp-content/themes/smph/images/card-fallback.png.webp)
Gene therapy for type 1 diabetes aims to eliminate daily insulin injections
Researchers at the University of Wisconsin School of Medicine and Public Health are one step closer to developing a gene therapy for Type 1 diabetes mellitus – a development that could one day eliminate the need for daily insulin shots and provide a way to better regulate glucose metabolism, a factor critical for preventing the most problematic complications of the disease.
![](https://www.med.wisc.edu/wp-content/themes/smph/images/card-fallback.png.webp)
New study shows how cells can be led down non-cancer path
As cells with a propensity for cancer break down food for energy, they reach a fork in the road: They can either continue energy production as healthy cells, or shift to the energy production profile of cancer cells.
![](https://www.med.wisc.edu/wp-content/themes/smph/images/card-fallback.png.webp)
Study finds people with Alzheimer’s disease have altered gut bacteria
Changes in gut bacteria could be linked to Alzheimer’s disease, according to a new study from the University of Wisconsin School of Medicine and Public Health.
![](https://www.med.wisc.edu/wp-content/themes/smph/images/card-fallback.png.webp)
Study shows HPV works across cellular borders to drive cervical cancer
Human papillomavirus (HPV) and the hormone estrogen are both linked to the development of cervical cancers, but how they work together has remained unclear.
![](https://www.med.wisc.edu/wp-content/themes/smph/images/card-fallback.png.webp)
Researchers discover how two gene enhancers control blood cell development
A group of researchers from the University of Wisconsin School of Medicine and Public Health (SMPH) has unearthed a critical process in how healthy red blood cells are produced.
![](https://www.med.wisc.edu/wp-content/themes/smph/images/card-fallback.png.webp)
Researchers team up to find new therapies for childhood MDS, leukemia
Two researchers from the University of Wisconsin School of Medicine and Public Health will join forces to discover how a particular gene could affect a deadly, rare childhood genetic disease.
![](https://www.med.wisc.edu/wp-content/themes/smph/images/card-fallback.png.webp)
Researchers study real-time flu surveillance
High-tech flu surveillance within clinics can accurately track, in real time, early flu activity, peak season and the end of the flu season, according to University of Wisconsin School of Medicine and Public Health researchers.
![](https://www.med.wisc.edu/wp-content/themes/smph/images/card-fallback.png.webp)
CLR 131 found to broadly target pediatric solid tumors
According to a new study by UW Carbone Cancer Center (UWCCC) researchers, a broadly applicable cancer therapy currently being developed by Cellectar Biosciences may have the potential to work in pediatric solid tumors.